US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist

19.340
+0.680+3.64%

Close Dec 20 16:00 ET

19.340
0.0000.00%

Post 16:07 ET

123.65MMarket Cap-1.18P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

10.21%-8.13M

-8.42%-5.94M

-28.11%-6.67M

-250.71%-28.71M

-210.02%-8.97M

-366.91%-9.06M

-297.60%-5.48M

-163.49%-5.2M

50.92%-8.19M

19.24%-2.89M

Net income from continuing operations

15.70%-8.39M

-40.64%-12.51M

-9.88%-7.42M

-126.79%-31.48M

-20.40%-5.87M

-192.79%-9.96M

-193.11%-8.9M

-163.07%-6.75M

36.07%-13.88M

-45.97%-4.88M

Depreciation and amortization

233.33%10K

--10K

--9K

--6K

--3K

--0

Other non cash items

----

---131K

----

Change In working capital

-329.58%-551K

122.96%5.77M

-108.18%-55K

-123.35%-392K

-446.17%-3.89M

-56.68%240K

457.54%2.59M

245.14%672K

133.19%1.68M

176.00%1.12M

-Change in prepaid assets

98.50%-13K

-122.08%-17K

206.59%279K

-429.07%-849K

-182.42%-150K

-335.68%-867K

-67.37%77K

133.33%91K

-78.87%258K

-63.82%182K

-Change in payables and accrued expense

-148.60%-538K

130.48%5.79M

-157.49%-334K

-67.84%457K

-497.13%-3.74M

47.01%1.11M

1,000.88%2.51M

215.74%581K

383.63%1.42M

147.53%942K

Cash from discontinued investing activities

Operating cash flow

10.21%-8.13M

-8.42%-5.94M

-28.11%-6.67M

-250.71%-28.71M

-210.02%-8.97M

-366.91%-9.06M

-297.60%-5.48M

-163.49%-5.2M

50.92%-8.19M

19.24%-2.89M

Investing cash flow

Cash flow from continuing investing activities

-6K

47K

-16K

10.03M

-9.97M

Net PPE purchase and sale

--0

---6K

---88K

---17K

---71K

--0

Net investment purchase and sale

--0

----

--135K

--1K

--10.1M

----

--0

Cash from discontinued investing activities

Investing cash flow

--0

---6K

--47K

---16K

--10.03M

---9.97M

--0

Financing cash flow

Cash flow from continuing financing activities

-100.01%-2K

58.33%-10K

-233.33%-8K

240.89%24.68M

-36.36%-75K

233.02%24.78M

78.18%-24K

117.65%6K

16,556.82%7.24M

-41.03%-55K

Net common stock issuance

----

242.07%24.73M

-16.36%-64K

----

--7.23M

---55K

Proceeds from stock option exercised by employees

-33.33%6K

--0

33.33%8K

33.33%16K

--1K

--9K

--0

-50.00%6K

-80.65%12K

--0

Net other financing activities

70.83%-7K

---10K

---16K

---60K

---12K

---24K

----

Cash from discontinued financing activities

Financing cash flow

-100.01%-2K

58.33%-10K

-233.33%-8K

240.89%24.68M

-36.36%-75K

233.02%24.78M

78.18%-24K

117.65%6K

16,556.82%7.24M

-41.03%-55K

Net cash flow

Beginning cash position

19.86%24.5M

-15.20%30.44M

-9.67%37.13M

-2.25%41.1M

4.85%46.19M

-46.98%20.44M

-10.32%35.9M

-2.25%41.1M

-28.45%42.04M

-3.54%44.05M

Current changes in cash

-131.60%-8.14M

61.55%-5.95M

-28.53%-6.68M

-321.08%-3.98M

-207.33%-9.06M

368.13%25.75M

-939.95%-15.46M

-158.74%-5.2M

94.35%-944K

18.59%-2.95M

End cash Position

-64.57%16.36M

19.86%24.5M

-15.20%30.44M

-9.67%37.13M

4.85%46.19M

-46.98%20.44M

-10.32%35.9M

-2.25%41.1M

Free cash flow

10.91%-8.13M

-8.42%-5.94M

-28.23%-6.67M

-251.79%-28.79M

-210.61%-8.99M

-370.57%-9.13M

-297.60%-5.48M

-163.49%-5.2M

50.92%-8.19M

19.24%-2.89M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	10.21%-8.13M	-8.42%-5.94M	-28.11%-6.67M	-250.71%-28.71M	-210.02%-8.97M	-366.91%-9.06M	-297.60%-5.48M	-163.49%-5.2M	50.92%-8.19M	19.24%-2.89M
Net income from continuing operations	15.70%-8.39M	-40.64%-12.51M	-9.88%-7.42M	-126.79%-31.48M	-20.40%-5.87M	-192.79%-9.96M	-193.11%-8.9M	-163.07%-6.75M	36.07%-13.88M	-45.97%-4.88M
Depreciation and amortization	233.33%10K	--10K	--9K	--9K	--6K	--3K	--0	--0	--0	--0
Other non cash items	----	----	----	---131K	----	----	----	----	----	----
Change In working capital	-329.58%-551K	122.96%5.77M	-108.18%-55K	-123.35%-392K	-446.17%-3.89M	-56.68%240K	457.54%2.59M	245.14%672K	133.19%1.68M	176.00%1.12M
-Change in prepaid assets	98.50%-13K	-122.08%-17K	206.59%279K	-429.07%-849K	-182.42%-150K	-335.68%-867K	-67.37%77K	133.33%91K	-78.87%258K	-63.82%182K
-Change in payables and accrued expense	-148.60%-538K	130.48%5.79M	-157.49%-334K	-67.84%457K	-497.13%-3.74M	47.01%1.11M	1,000.88%2.51M	215.74%581K	383.63%1.42M	147.53%942K
Cash from discontinued investing activities
Operating cash flow	10.21%-8.13M	-8.42%-5.94M	-28.11%-6.67M	-250.71%-28.71M	-210.02%-8.97M	-366.91%-9.06M	-297.60%-5.48M	-163.49%-5.2M	50.92%-8.19M	19.24%-2.89M
Investing cash flow
Cash flow from continuing investing activities	0	0	-6K	47K	-16K	10.03M	-9.97M	0	0	0
Net PPE purchase and sale	--0	--0	---6K	---88K	---17K	---71K	--0	--0	--0	--0
Net investment purchase and sale	--0	----	----	--135K	--1K	--10.1M	----	----	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	---6K	--47K	---16K	--10.03M	---9.97M	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	-100.01%-2K	58.33%-10K	-233.33%-8K	240.89%24.68M	-36.36%-75K	233.02%24.78M	78.18%-24K	117.65%6K	16,556.82%7.24M	-41.03%-55K
Net common stock issuance	----	----	----	242.07%24.73M	-16.36%-64K	----	----	----	--7.23M	---55K
Proceeds from stock option exercised by employees	-33.33%6K	--0	33.33%8K	33.33%16K	--1K	--9K	--0	-50.00%6K	-80.65%12K	--0
Net other financing activities	70.83%-7K	---10K	---16K	---60K	---12K	---24K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-100.01%-2K	58.33%-10K	-233.33%-8K	240.89%24.68M	-36.36%-75K	233.02%24.78M	78.18%-24K	117.65%6K	16,556.82%7.24M	-41.03%-55K
Net cash flow
Beginning cash position	19.86%24.5M	-15.20%30.44M	-9.67%37.13M	-2.25%41.1M	4.85%46.19M	-46.98%20.44M	-10.32%35.9M	-2.25%41.1M	-28.45%42.04M	-3.54%44.05M
Current changes in cash	-131.60%-8.14M	61.55%-5.95M	-28.53%-6.68M	-321.08%-3.98M	-207.33%-9.06M	368.13%25.75M	-939.95%-15.46M	-158.74%-5.2M	94.35%-944K	18.59%-2.95M
End cash Position	-64.57%16.36M	19.86%24.5M	-15.20%30.44M	-9.67%37.13M	-9.67%37.13M	4.85%46.19M	-46.98%20.44M	-10.32%35.9M	-2.25%41.1M	-2.25%41.1M
Free cash flow	10.91%-8.13M	-8.42%-5.94M	-28.23%-6.67M	-251.79%-28.79M	-210.61%-8.99M	-370.57%-9.13M	-297.60%-5.48M	-163.49%-5.2M	50.92%-8.19M	19.24%-2.89M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data